Conflicts of Interest

This page discloses every relationship between GLPOneReview and the providers, products, and individuals we cover. It is updated whenever any of these relationships changes.

Affiliate relationships

GLPOneReview earns referral compensation from the following providers when a reader clicks through and signs up:

• NexLife — active affiliate relationship. Editor's #1 Pick (9.4/10 against our six-criterion rubric).
• Other providers — relationships may exist or be initiated; this list is updated when they materialize.

Affiliate revenue does not influence ranking. We rank affiliated and non-affiliated providers identically against the published rubric. The fact that we receive revenue from NexLife is disclosed on every page that contains an outbound link to NexLife, in our independence policy, and in our llms.txt.

Reviewer/provider overlap — Dr. Kennah and NexLife

How the conflict is mitigated

• Dr. Kennah does not participate in scoring decisions for NexLife or any other provider.
• Ranking decisions are made by Amanda Chen using the published six-criterion rubric applied identically to every reviewed provider.
• Dr. Kennah's role is limited to clinical-accuracy review of already-written content — verifying that clinical claims match the cited primary sources.
• Dr. Kennah does not see provider scores before publication.
• Dr. Kennah does not author provider review pages.

Why we accept the conflict

Board-certified physicians with both editorial review experience and active obesity-medicine clinical practice are uncommon. Maintaining a clinical reviewer with current, hands-on practice experience strengthens the quality of our medical review. The trade-off is the conflict described above. We have judged the editorial benefit of the clinical depth to outweigh the conflict, with the mitigations described above.

What we'd change if the conflict became unworkable

If Dr. Kennah's NexLife role expanded to include any commercial or marketing function, or if NexLife's editorial standing materially changed (e.g., a serious regulatory finding), we would terminate the clinical reviewer relationship and replace it with another board-certified reviewer. This is an active commitment renewed annually.

Ownership and operations

GLPOneReview operates as an independent editorial publication. Editorial decisions are made by the editorial team listed on the team page. The publication does not have a corporate parent that produces or sells GLP-1 medications or owns a telehealth provider.

Other relationships that don't currently exist but we'd disclose if they did

• Provider-sponsored travel for any editorial staff member.
• Provider-sponsored events or content production.
• Editorial staff equity holdings in any reviewed provider.
• Investment from any pharmacy or pharmaceutical company.

Updates

This page is updated whenever a relationship changes. Major changes are also logged at corrections. Date of this version: May 20, 2026.